Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127880 · ClinicalTrials.gov registry record · Phase 2
Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax
A Phase 2 study of Pneumothorax and Hemopneumothorax, sponsored by St. Luke's Hospital, Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01127880: Completed Phase 2 study of Pneumothorax and Hemopneumothorax, sponsored by St. Luke's Hospital, Pennsylvania.
NCT01127880 is a Phase 2 study of Pneumothorax and Hemopneumothorax that has completed, run by St. Luke's Hospital, Pennsylvania. The registered enrollment target is 50 participants, below the 636-participant average among 6 other Pneumothorax trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01127880, a Phase 2 study of Pneumothorax and Hemopneumothorax, has completed, sponsored by St. Luke's Hospital, Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the efficacy of prophylactic antibiotics in patients with chest tubes for management of thoracic injuries in the reduction of the incidence of empyema as compared to placebo.
Primary Outcome
The primary objective of this study is to examine the efficacy of prophylactic antibiotics in patients with chest tubes for management of thoracic injuries in the reduction of the incidence of empyema as compared to placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ancef or Clindamycin
Study Locations (1)
Pennsylvania
- St. Luke's Hospital and Health Network - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-07 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
What the finished NCT01127880 record still lists
NCT01127880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 636-participant average among 6 other Pneumothorax trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Pneumothorax appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01127880 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01127880 about?
NCT01127880 is a clinical study titled "Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax". The purpose of this study is to examine the efficacy of prophylactic antibiotics in patients with chest tubes for management of thoracic injuries in the reduction of the incidence of empyema as compared to placebo.
What is the current status of trial NCT01127880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2005-07. Estimated completion is 2009-12.
What conditions does trial NCT01127880 study?
This clinical trial studies the following conditions: Pneumothorax, Hemopneumothorax.
What interventions are being tested in trial NCT01127880?
The interventions under investigation include: Placebo (DRUG), Ancef or Clindamycin (DRUG).
Who is sponsoring clinical trial NCT01127880?
This trial is sponsored by St. Luke's Hospital, Pennsylvania, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01127880 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumothorax
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
RECRUITING
-
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RECRUITING
-
Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks
RECRUITING · NA
-
Study of the Disease Process of Lymphangioleiomyomatosis
RECRUITING
-
Drainage Amount for Removal of Thoracostomy Tube
COMPLETED · NA
-
Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia